This site is intended for healthcare professionals
Industry news

Allergan acquires oral CGRP receptor antagonists from Merck Inc. including MK 1602 and MK 8031

Read time: 1 mins
Last updated:8th Jul 2015
Published:8th Jul 2015
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest